Financials
- Market Capitalization 27.26 M
- Employee 28
- Founded 1996
- CEO N/A
- Website www.plustherapeutics.com
- Headquarter Delaware, United States
- FIGI BBG000C1Z086
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 4489 | SER Serina Therapeutics, Inc. Common Stock | 1.97 USD | -7.94% | -7.94% | +7.07% | +18.32% | 29.55 M USD | ||
| 4499 | ATNM Actinium Pharmaceuticals, Inc. Common Stock | 0.91 USD | +1.11% | -9.00% | -10.78% | -12.50% | 28.55 M USD | ||
| 4512 | CRVO CervoMed Inc. - Common Stock | 2.95 USD | -4.22% | -13.49% | -11.94% | -59.31% | 27.31 M USD | ||
| 4517 | IGC IGC Pharma, Inc. Common Stock | 0.27 USD | 0.00% | -3.57% | -6.90% | +5.39% | 27.02 M USD |
Frequently asked questions about PLUS THERAPEUTICS, Inc. - Common Stock
What is the PLUS THERAPEUTICS, Inc. - Common Stock stock price today?
The current price of PLUS THERAPEUTICS, Inc. - Common Stock (PSTV) is 3.96. Over the past 24 hours, the stock has changed by -7.48%. Follow the PSTV chart for real-time price dynamics.
What is the stock ticker of PLUS THERAPEUTICS, Inc. - Common Stock?
PLUS THERAPEUTICS, Inc. - Common Stock trades under the ticker PSTV. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is PLUS THERAPEUTICS, Inc. - Common Stock stock going up?
PSTV has changed by +6.45% over the last week, -18.35% over the last month, and +1137.50% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was PLUS THERAPEUTICS, Inc. - Common Stock net income for the last quarter?
PLUS THERAPEUTICS, Inc. - Common Stock reported net income of -6.95 M for the last quarter. The previous quarter showed -5.71 M, which means net income changed by -21.58%.
How many employees does PLUS THERAPEUTICS, Inc. - Common Stock have?
As of the latest available data, PLUS THERAPEUTICS, Inc. - Common Stock has 28 employees. Workforce size can provide additional context about the company's scale and operations.
What is PLUS THERAPEUTICS, Inc. - Common Stock EBITDA?
PLUS THERAPEUTICS, Inc. - Common Stock EBITDA is -7.02 M, and its EBITDA margin is -683.17%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy PLUS THERAPEUTICS, Inc. - Common Stock stock?
You can buy PLUS THERAPEUTICS, Inc. - Common Stock (PSTV) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in PLUS THERAPEUTICS, Inc. - Common Stock stock?
Investing in PLUS THERAPEUTICS, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the PSTV chart and related analysis on metatrader.com as part of your research.